In the Phase 3 TRIUMPH-4 trial, a new safety signal called dysesthesia (abnormal skin sensations like tingling or burning) appeared in up to 20.9% of patients on the highest dose
When it comes to treatment goals, the medications fall into two main categories: those targeting type 2 diabetes (Ozempic, Rybelsus, Mounjaro, Victoza, and Trulicity) and those approved for weight management (Wegovy, Zepbound, and Saxenda)
Emerging Safety Concerns Recent research has identified new safety considerations beyond traditional gastrointestinal effects
"In the brain, it's thought to reduce food intake by some element of appetite suppression," says Evan Nadler, MD, MBA , former co-director of the obesity program at Children's National Hospital and current adjunct associate professor at George Washington University
So, how do you find a professional you can trust
Liver Metabolism and Hepatic Signaling Research